[CTXR] YoY Quarter Result on 31-Mar-2022 [#Q2]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q2]
Profit Trend
QoQ- 18.36%
YoY- -82.70%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,400 -10,382 -7,561 -4,122 -4,425 -3,632 -4,422 11.27%
Tax 144 144 -30 69 12 14 5 74.98%
NP -8,544 -10,526 -7,531 -4,122 -4,425 -3,632 -4,422 11.59%
Tax Rate - - - - - - - -
Total Cost 8,544 10,526 7,531 4,122 4,425 3,632 4,422 11.59%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.05 -0.07 -0.05 -0.04 -0.13 -0.20 -0.44 -30.38%
EPS Diluted -0.05 -0.07 -0.05 -0.04 -0.13 -0.20 -0.44 -30.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.